These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 11586021)

  • 1. A Case of pemphigus foliaceus which occurred after five years of remission from pemphigus vulgaris.
    Kimoto M; Ohyama M; Hata Y; Amagai M; Nishikawa T
    Dermatology; 2001; 203(2):174-6. PubMed ID: 11586021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
    Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
    J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris.
    Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
    Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.
    Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T
    Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous pemphigus vulgaris with absence of desmoglein 1 autoantibodies. An example of the extended desmoglein compensation theory.
    Carew B; Wagner G
    Australas J Dermatol; 2014 Nov; 55(4):292-5. PubMed ID: 25399788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus.
    Cirillo N; Santoro R; Lanza M; Annese P; Gombos F; Lanza A
    Clin Exp Dermatol; 2008 Jan; 33(1):32-5. PubMed ID: 17983457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
    Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
    Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
    Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
    Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3.
    Harman KE; Gratian MJ; Seed PT; Bhogal BS; Challacombe SJ; Black MM
    Clin Exp Dermatol; 2000 May; 25(3):236-40. PubMed ID: 10844505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diagnostic value of indirect immunofluorescence assay and desmoglein ELISA in the diagnosis of pemphigus.
    Marinović B; Fabris Z; Lipozencić J; Stulhofer Buzina D; Lakos Jukić I
    Acta Dermatovenerol Croat; 2010; 18(2):79-83. PubMed ID: 20624356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects and immunopathology in 48 patients with pemphigus].
    Hahn K; Kippes W; Amagai M; Rzany B; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):670-7. PubMed ID: 11057394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus.
    Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T
    J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of desmoglein 1 and 3 immunohistochemistry with autoantibody levels and clinical severity in pemphigus.
    Pradeep A; Eapen M; Jagadeeshan S; Kani K
    J Cutan Pathol; 2023 Dec; 50(12):1104-1109. PubMed ID: 37584110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.
    Spindler V; Drenckhahn D; Zillikens D; Waschke J
    Am J Pathol; 2007 Sep; 171(3):906-16. PubMed ID: 17640963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.